Log In
Print
BCIQ
Print
Print this Print this
 

Diane 35, cyproterone/ethinylestradiol

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionFixed-dose combination of 2 mg cyproterone acetate and 35 ug ethinylestradiol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today